The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma

Lauren A. Seserko, Joshua F. Emory, Craig Hendrix, Mark A Marzinke

Research output: Contribution to journalArticle

Abstract

Background: Dapivirine is a non-nucleoside reverse transcriptase inhibitor designed to prevent HIV-1 viral replication and subsequent propagation. A sensitive method is required to quantify plasma concentrations to assess drug efficacy. Results: Dapivirine-spiked plasma was combined with acetonitrile containing deuterated IS and was processed for analysis. The method has an analytical measuring range from 20 to 10,000 pg/ml. For the LLOQ, low, mid and high QCs, intra- and inter-assay precision (%CV) ranged from 5.58 to 13.89% and 5.23 to 13.36%, respectively, and intra- and inter-day accuracy (% deviation) ranged from -5.61 to 0.75% and -4.30 to 6.24%, respectively. Conclusion: A robust and sensitive LC-MS/MS assay for the high-throughput quantification of the antiretroviral drug dapivirine in human plasma was developed and validated following bioanalytical validation guidelines. The assay meets criteria for the analysis of samples from large research trials.

Original languageEnglish (US)
Pages (from-to)2771-2783
Number of pages13
JournalBioanalysis
Volume5
Issue number22
DOIs
StatePublished - Nov 2013

Fingerprint

Anti-Retroviral Agents
Plasma (human)
Assays
Reverse Transcriptase Inhibitors
Plasmas
Pharmaceutical Preparations
HIV-1
Guidelines
Throughput
Research
TMC120-R147681

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Medical Laboratory Technology
  • Analytical Chemistry

Cite this

The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma. / Seserko, Lauren A.; Emory, Joshua F.; Hendrix, Craig; Marzinke, Mark A.

In: Bioanalysis, Vol. 5, No. 22, 11.2013, p. 2771-2783.

Research output: Contribution to journalArticle

@article{55410532238b4486841b39771dcb29db,
title = "The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma",
abstract = "Background: Dapivirine is a non-nucleoside reverse transcriptase inhibitor designed to prevent HIV-1 viral replication and subsequent propagation. A sensitive method is required to quantify plasma concentrations to assess drug efficacy. Results: Dapivirine-spiked plasma was combined with acetonitrile containing deuterated IS and was processed for analysis. The method has an analytical measuring range from 20 to 10,000 pg/ml. For the LLOQ, low, mid and high QCs, intra- and inter-assay precision ({\%}CV) ranged from 5.58 to 13.89{\%} and 5.23 to 13.36{\%}, respectively, and intra- and inter-day accuracy ({\%} deviation) ranged from -5.61 to 0.75{\%} and -4.30 to 6.24{\%}, respectively. Conclusion: A robust and sensitive LC-MS/MS assay for the high-throughput quantification of the antiretroviral drug dapivirine in human plasma was developed and validated following bioanalytical validation guidelines. The assay meets criteria for the analysis of samples from large research trials.",
author = "Seserko, {Lauren A.} and Emory, {Joshua F.} and Craig Hendrix and Marzinke, {Mark A}",
year = "2013",
month = "11",
doi = "10.4155/bio.13.256",
language = "English (US)",
volume = "5",
pages = "2771--2783",
journal = "Bioanalysis",
issn = "1757-6180",
publisher = "Future Science",
number = "22",

}

TY - JOUR

T1 - The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma

AU - Seserko, Lauren A.

AU - Emory, Joshua F.

AU - Hendrix, Craig

AU - Marzinke, Mark A

PY - 2013/11

Y1 - 2013/11

N2 - Background: Dapivirine is a non-nucleoside reverse transcriptase inhibitor designed to prevent HIV-1 viral replication and subsequent propagation. A sensitive method is required to quantify plasma concentrations to assess drug efficacy. Results: Dapivirine-spiked plasma was combined with acetonitrile containing deuterated IS and was processed for analysis. The method has an analytical measuring range from 20 to 10,000 pg/ml. For the LLOQ, low, mid and high QCs, intra- and inter-assay precision (%CV) ranged from 5.58 to 13.89% and 5.23 to 13.36%, respectively, and intra- and inter-day accuracy (% deviation) ranged from -5.61 to 0.75% and -4.30 to 6.24%, respectively. Conclusion: A robust and sensitive LC-MS/MS assay for the high-throughput quantification of the antiretroviral drug dapivirine in human plasma was developed and validated following bioanalytical validation guidelines. The assay meets criteria for the analysis of samples from large research trials.

AB - Background: Dapivirine is a non-nucleoside reverse transcriptase inhibitor designed to prevent HIV-1 viral replication and subsequent propagation. A sensitive method is required to quantify plasma concentrations to assess drug efficacy. Results: Dapivirine-spiked plasma was combined with acetonitrile containing deuterated IS and was processed for analysis. The method has an analytical measuring range from 20 to 10,000 pg/ml. For the LLOQ, low, mid and high QCs, intra- and inter-assay precision (%CV) ranged from 5.58 to 13.89% and 5.23 to 13.36%, respectively, and intra- and inter-day accuracy (% deviation) ranged from -5.61 to 0.75% and -4.30 to 6.24%, respectively. Conclusion: A robust and sensitive LC-MS/MS assay for the high-throughput quantification of the antiretroviral drug dapivirine in human plasma was developed and validated following bioanalytical validation guidelines. The assay meets criteria for the analysis of samples from large research trials.

UR - http://www.scopus.com/inward/record.url?scp=84889584113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889584113&partnerID=8YFLogxK

U2 - 10.4155/bio.13.256

DO - 10.4155/bio.13.256

M3 - Article

C2 - 24256358

AN - SCOPUS:84889584113

VL - 5

SP - 2771

EP - 2783

JO - Bioanalysis

JF - Bioanalysis

SN - 1757-6180

IS - 22

ER -